SPOTLIGHT -
UK Orders Large Quantity of Pfizer mRNA Vaccine
The development of BNT162 is based on BioNTech’s mRNA platform; the vaccine will then be produced using Pfizer’s vaccine manufacturing capacities.
Read More
Applying African Ebola Response Experience to the Coronavirus Pandemic
West and Central African nations have been developing infrastructure to combat ebola, malaria, malnutrition, and more.
FDA-Approved Anticoagulant May Stop Coronavirus From Binding to Human Cells
Heparin may lower the odds of SARS-CoV-2 infection, according to investigators from the Rensselaer Polytechnic Institute.
COVID-19 Could Raise HIV, TB, Malaria Death Rates
A modeling study from Imperial College shows the pandemic may have significant effect on mortality among other infectious disease patients.
FDA Cyclospora Outbreak Investigation: 500+ Cases Across 8 States
Mylan Pharmaceuticals also announced that a batch of daptomycin has been recalled due to contamination.
Remdesivir: Gilead Touts Promising Coronavirus Outcomes Across Race & Ethnicity
Findings were announced during the special COVID-19 sessions of the virtual 23rd International AIDS Conference.
Cash for Clinic Visits: Financial Incentive Boosts HIV Viral Suppression
Investigators in Tanzania trialed modest, automated financial incentives for clinic attendance on viral suppression for patients initiating ART.
Event-Driven PrEP Patients Face Retention Issues in Thai Study
Investigators compared characteristics and retention between daily and event-driven PrEP patients to better understand low uptake of event-driven PrEP.
Overdose Deaths Encroach on Life Expectancy Gains Among People Living With HIV
Experts assessed the impact of drug overdoses on people living with HIV in British Columbia, identifying factors associated with mortality using competing risk methodology.
Money, Pills, and Isolation: Survey Reveals Concerns of Aging Patients With HIV
People with HIV are living longer than ever at present time, raising quality of life concerns about later stage medical and psychological challenges comorbidities.
California PrEP Push Reveals Underserved Demographics
The California PrEP Assistance Program, established to remove financial and structural barriers to PrEP access, had positive but uneven initial results.
Combatting Virologic Failure in Children with HIV using Targeted Drug Resistance Testing
Guidelines recommend concentrated adherence counseling and frequent viral load testing for virologic failure, but drug resistance testing is often excluded.
International Survey Suggests Elderly Adults Have Ambivalent Views on COVID-19 Guidelines
Despite being within the age group at highest risk for severe SARS-CoV-2 infection, a recent survey suggests that the population is not inherently more willing to socially isolate.
UNAIDS Report: Inequality and Coronavirus Risk a Decade of HIV Progress
A report released for AIDS 2020 warns the international AIDS response could be set back substantially by ongoing events.
Clinics Test Long-Acting HIV Therapy Implementation Strategies in Cabotegravir-Rilpivirine Trial
CUSTOMIZE was designed to identify methods of implementing an experimental once-monthly, long-acting regimen antiretroviral therapy against HIV-1 into clinical practice.
Top FDA Recalls: Mystic Shield Protection Topical Solution, Pasta With Listeria Risk
. The following is a list of key recalls that may be relevant to infectious diseases, with links to full recall statements.
Ebola Vaccine Regimen Receives European Commission Marketing Authorization
The European Commission has granted Marketing Authorization for a 2-dose Ebola vaccine regimen.
FDA: Coronavirus Vaccines Must Protect >50% Vaccinated Individuals
New recommendations are intended to aid biomedical firms in achieving licensure of a safe and effective vaccine.
UK Regulators Approve Phase 2/3 Study of Opaganib for COVID-19
Opaganib is set to be evaluated against SARS-CoV-2 in a multi-center, randomized, parallel arm, double-blind, placebo-controlled study.
Toxic Hand Sanitizer Recalled After FDA Alert
“Anti-Viral Immune Enhancement” also recalled due to unsubstantiated coronavirus claims.
FDA Delays Nabriva Approval, Citing Inability to Conduct Inspections Amid COVID-19
The infectious disease pharmaceutical and medical device pipeline is always evolving. See a round-up of our FDA drug pipeline coverage from the past week:
HHS to Receive $32M Worth of Smallpox Drug
While smallpox may not be in headlines today, the illness (treated with tecovirimat) remains a threat.
Hong Kong Experts: Are Masks an Independently Significant Coronavirus Intervention?
The Hong Kong researchers used online searches to quantify public interest in mask usage.
Updated IDSA Coronavirus Guidelines Address Remdesivir, Plasma, & More
Given research into SARS-CoV-2 is taking place at unprecedented speed, the panel of IDSA experts had to decide on current best practices using science which is still in motion.
Gilead CEO: Inhaled Form of Remdesivir May Mitigate Coronavirus Hospitalizations
In order to expand the potential uses of the drug against SARS-CoV-2, Gilead Sciences has announced plans to explore administration of remdesivir in an inhaled form.
Investigational PCV Meets Safety and Immunogenicity Objectives in Initial Phase 3 Studies
Data were published using the International Symposium on Pneumococci and Pneumococcal Diseases online digital library.
Chinese Local CDC Data on Household Transmission of SARS-CoV-2
In a new analysis of Guangzhou city contact tracing data, investigators examined secondary attack rates of SARS-CoV-2.
IV-to-Oral Antibiotic Courses May Reduce Invasive Infection Readmissions During Opioid Epidemic
Providing oral antibiotics to people who inject drugs with infections may reduce hospital readmissions.
FDA Issues EUA for COVID-19 Predictive Analytics Platform
The technology deploys AI-based algorithms that use machine-learning to identify respiratory failure and hemodynamic instability
The ID Pipeline: New Dolutegravir Indication, Latest COVID-19 EUAs
The US FDA is a key global regulatory authority. Here are updates from this week on the FDA pipeline, particularly concerning infectious diseases: